1. Home
  2. MEI vs ENTA Comparison

MEI vs ENTA Comparison

Compare MEI & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methode Electronics Inc.

MEI

Methode Electronics Inc.

HOLD

Current Price

$12.02

Market Cap

398.2M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$11.90

Market Cap

382.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEI
ENTA
Founded
1946
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
382.7M
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
MEI
ENTA
Price
$12.02
$11.90
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$9.00
$20.40
AVG Volume (30 Days)
739.3K
187.1K
Earning Date
03-05-2026
05-11-2026
Dividend Yield
2.61%
N/A
EPS Growth
49.14
29.93
EPS
N/A
N/A
Revenue
$908,300,000.00
$102,814,000.00
Revenue This Year
N/A
$7.76
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.24
16.48
52 Week Low
$4.88
$6.44
52 Week High
$15.55
$17.15

Technical Indicators

Market Signals
Indicator
MEI
ENTA
Relative Strength Index (RSI) 58.29 41.97
Support Level $6.70 $11.92
Resistance Level $13.53 $13.97
Average True Range (ATR) 0.83 0.75
MACD -0.19 -0.08
Stochastic Oscillator 54.04 33.69

Price Performance

Historical Comparison
MEI
ENTA

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: